Robertson Stephens Advisors’s Merck MRK Stock Holding History

Robertson Stephens Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,811	Closed	-$329K	–	120
2016 Q4	$329K	Buy	+5,811	New	+$340K	0.19%	108

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Robertson Stephens Advisors's MRK Position: Q1 2017 in Review

Robertson Stephens Advisors sold out of Merck (MRK) in Q1 2017, closing a stake of 5,811 shares — an estimated $329K sold.

Robertson Stephens Advisors first reported a position in MRK in Q4 2016 and held it in 1 quarter. The position peaked at $329K in Q4 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

Robertson Stephens Advisors reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
Robertson Stephens Advisors sold 5,811 Merck shares in Q1 2017, an estimated $329K.
Robertson Stephens Advisors first reported a position in Merck in Q4 2016 and held it in 1 quarter.
Robertson Stephens Advisors's Merck position peaked at $329K in Q4 2016.
1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Robertson Stephens Advisors's 13F filing for Q1 2017, filed 12 May 2017.